ROLE OF PROLONGED REPOLARIZATION IN CARDIAC ARRHYTHMIAS
ROLE OF PROLONGED REPOLARIZATION IN CARDIAC ARRHYTHMIAS
批准号:
3344120
负责人:
DAN M RODEN
金额:
$10.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-08-01 至 1993-03-31
关键词:
action potentials amiodarone antiarrhythmic agent disease /disorder model disease /disorder proneness /risk disopyramide dogs drug adverse effect electrocardiography electrophysiology guinea pigs heart disorder chemotherapy heart disorder diagnosis heart pharmacology human subject human therapy evaluation hypokalemia magnesium deficiency potassium channel procainamide quinidine sudden cardiac death tachycardia
中文摘要
人们对延长的概念有着浓厚的兴趣
英文摘要
There is intense interest in the concept that prolongation of
cardiac repolarization may be an important mechanism whereby
drugs suppress arrhythmias. However, marked repolarization
increases have also been associated with induction of arrhythmias.
Our initial clinical and in vitro studies of this arrhythmia-
provoking action demonstrated that long cycle lengths and low
extracellular potassium markedly potentiated the repolarization-
prolonging effect of quinidine; under these conditions, a
distinctive polymorphic ventricular tachycardia (Torsades de
Pointes) developed in patients and early after depolarizations
(EADS) were elicited in canine Purkinje fibers. In the previous
period of support, studies were conducted to further evaluate our
working hypothesis that EADs are linked to the genesis of
Torsades de Pointes. One of the most important findings to date
is that ventricular muscle blunts the action potential prolongation
and EAD induction by quinidine in Purkinje tissue. We will now
further examine the impact of modulation of Purkinje-ventricular
coupling by interventions such as altered Cai (e.g. digitalis) and
Cao, drugs (quinidine, amiodarone) and medium chain alcohols.
We have implemented a computer model of porpagating Purkinje
and ventricular muscle action potentials liked with variable axial
resistivities in a one-dimensional cable which will be refined in
parallel with experimental results. In this way, the hypothesis
that EADs cause arrhythmias in vivo will be further tested and
conditions which are important for the genesis or suppression of
EAD-mediated arrhythmias identified.
Despite increasing interest in the use of repolarization-prolonging
drugs in the management of cardiac arrhythmias, little
information is available on the ionic mechanism(s) whereby they
exert this effect. In the past year we have accumulated evidence
that the interaction of quinidine and amiodarone with the delayed
rectifier IK (a repolarizing current) in voltage-clamped guinea pig
ventricular myocytes is time- and voltage-dependent. These date
suggest that drug effects on IK are modulated by the state of this
potassium channel. A second major goal of the studies we now
propose is to further test this hypothesis. We will initially
characterize the effects of quinidine and amiodarone on IK as a
function of initial channel state. Subsequently, we will examine
the effects of these and other structurally related agents in other
tissues (Purkinje, atrial). The results will not only characterize
the impact of channel state on drug effect, but will also be used
to quantify drug action in a multistate model of drug-channel
interactions. Through this series of studies, therefore, we will
increase our understanding of the fundamental mechanisms
whereby drugs prolong repolarization and induce arrhythmias; in
this way, the development and clinical use of repolarization-
prolonging antiarrhythmic drugs will be improved.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vanderbilt Genome-Electronic Records (VGER) Project
-
批准号:10771648
-
项目类别:
-
资助金额:$10.66万
-
财政年份:2023
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome-Electronic Records (VGER) Project
-
批准号:10207727
-
项目类别:
-
资助金额:$144.81万
-
财政年份:2020
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome-Electronic Records (VGER) Project
-
批准号:10659136
-
项目类别:
-
资助金额:$136.74万
-
财政年份:2020
-
负责人:DAN M RODEN
-
依托单位:
Functional Genomics of Cardiac Sodium Channel Variants
-
批准号:10538620
-
项目类别:
-
资助金额:$73.54万
-
财政年份:2020
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome-Electronic Records (VGER) Project
-
批准号:10450009
-
项目类别:
-
资助金额:$144.81万
-
财政年份:2020
-
负责人:DAN M RODEN
-
依托单位:
SCN5A mutations and dilated cardiomyopathy
-
批准号:9275119
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2013
-
负责人:DAN M RODEN
-
依托单位:
SCN5A mutations and dilated cardiomyopathy
-
批准号:8651207
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2013
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome Electronic Records Project
-
批准号:8332920
-
项目类别:
-
资助金额:$11.16万
-
财政年份:2011
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome Electronic Records Project
-
批准号:8319346
-
项目类别:
-
资助金额:$76.41万
-
财政年份:2011
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome Electronic Records Project
-
批准号:8721555
-
项目类别:
-
资助金额:$19.87万
-
财政年份:2011
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome Electronic Records Project
-
批准号:8523192
-
项目类别:
-
资助金额:$101.6万
-
财政年份:2011
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome Electronic Records Project
-
批准号:8510828
-
项目类别:
-
资助金额:$18.97万
-
财政年份:2011
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome Electronic Records Project
-
批准号:8725217
-
项目类别:
-
资助金额:$99.48万
-
财政年份:2011
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome Electronic Records Project
-
批准号:8193577
-
项目类别:
-
资助金额:$77.27万
-
财政年份:2011
-
负责人:DAN M RODEN
-
依托单位:
Automated DNA Extraction for Small Volume Samples Enabling Pediatric Biobanking
-
批准号:7794409
-
项目类别:
-
资助金额:$13.95万
-
财政年份:2010
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome-Electronic Records Project
-
批准号:7922465
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2009
-
负责人:DAN M RODEN
-
依托单位:
Automated Storage and Retrieval of Biological Systems
-
批准号:7500018
-
项目类别:
-
资助金额:$98.83万
-
财政年份:2008
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome-Electronic Records Project
-
批准号:7893787
-
项目类别:
-
资助金额:$171.8万
-
财政年份:2007
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome-Electronic Records Project
-
批准号:7671509
-
项目类别:
-
资助金额:$165.8万
-
财政年份:2007
-
负责人:DAN M RODEN
-
依托单位:
Vanderbilt Genome-Electronic Records Project
-
批准号:7911405
-
项目类别:
-
资助金额:$22.94万
-
财政年份:2007
-
负责人:DAN M RODEN
-
依托单位:
海外基金